News Archive

EMA - Entry into application of EU Clinical Trial Regulation postponed to 2019

19th June 2017

The EMA Board discussed the progress made regarding the development of the EU clinical trial portal and database. Due to technical difficulties with the development of the IT systems, the portals go-live date has been postponed.

Read More+

Welcome to our new website

2nd June 2017

Welcome to our new website. We would appreciate any feedback you may have. Please send an e-mail to info@therqa.com with your comments.

Read More+

Green light given for new EudraVigilance system for collection and monitoring of suspected adverse reactions

30th May 2017

Management Board endorsement starts countdown for stakeholders to get ready for launch of improved system in November 2017 The European Medicines Agency (EMA) will launch a new and improved version of EudraVigilance, the European information system of suspected adverse reactions to medicines that are authorised or being studied in clinical trials in the European Economic Area (EEA). The new version of EudraVigilance will go live on 22 November 2017 with enhanced functionalities for reporting and analysing suspected adverse reactions.

Read More+

EMA and heads of national competent authorities discuss consequences of Brexit

22nd May 2017

Key principles and working methodology established The European Medicines Agency (EMA) organised an information meeting yesterday with members of its Management Board and heads of the National Competent Authorities (NCAs) of the EU/EEA Member States. The goal was to start discussing how the work related to the evaluation and monitoring of medicines will be shared between Member States in view of the United Kingdom’s (UK) withdrawal from the European Union.

Read More+

Major research funders and international NGOs to implement WHO standards on reporting clinical trial results

22nd May 2017

18 May 2017 | GENEVA - Some of the world’s largest funders of medical research and international non-governmental organizations today agreed on new standards that will require all clinical trials they fund or support to be registered and the results disclosed publicly.

Read More+